News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) Successfully Reinforces Pipeline With "Open Innovation"


4/28/2014 8:02:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Mene Pangalos is the man tasked with nothing less than firing up the discovery engine of Britain’s second-biggest drug maker after its catastrophic fall off the “patent cliff”. He joined AstraZeneca as head of innovative medicines in 2010, as the company was bracing for patents to expire on a string of its best-selling drugs. The Nineties had been productive for Astra, but the pipeline had dried up. Its research teams were still churning out plenty of “candidate” medicines, but most of them were failing when tested in real patients.

Help employers find you! Check out all the jobs and post your resume.

Read at Telegraph


comments powered by Disqus
Telegraph
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES